Abstract:Objective To investigate the efficacy and feasibility of segment-orientated anatomical liver resection for the treatment of hepatic alveolar echinococcosis (HAE) in the middle lobe of the liver.Methods The clinical data of a female patient with HAE in the middle lobe of the liver who was admitted to the First Affiliated Hospital of Xi'an Jiaotong University in September 2013 were retrospectively analyzed.Before operation,various surgical plannings were facilitated by a three-dimensional reconstruction system,and then the surgical planning was determined with the assistance of the multivariate analysis (volume measurement of liver,resectability of remnant functional liver,evaluation of vascular resection and reconstruction,Child-Pugh score and indocyanine green retention at 15 minutes).Segment-orientated anatomical liver resection(segment Ⅴ,Ⅷ and Ⅳb) was performed on the patient.There was a close relationship between the HAE and the first and the second hepatic portal during operation,and the anatomical liver resection of segment Ⅴ,Ⅷ and Ⅳb was precisely carried out.The patient was followed up by outpatient examination and telephone interview every month up to April 2014.The condition of the liver was observed by B ultrasound and computed tomography examinations.Results The three-dimensional reconstruction of the CT data of the patient clearly displayed the anatomical structure and adjacent relationship between the tumor,abdominal organs and major abdominal vessels.The preoperative evaluation of the anatomy of tumor based on three-dimensional images was confirmed with operative findings.The operation time and volume of blood loss were 410 minutes and 1 000 mL,respectively.The patient did not receive blood transfusion.The intraoperative vital signs of the patient were stable.There were no complications such as hepatic insufficiency.The duration of postoperative hospital stay was 15 days.Surgical incision was healed at discharge.The results of blood routine and blood biochemistry test,daily diet and basic self-care ability were in normal condition.HAE was diagnosed based on the result of pathological examination.Albendazole was administered with 1 200 mg/d after operation.The patient was followed up for 6 months and returned to work.The weight of the patient increased by 5 kilograms than that at discharge,without complaint of discomfort.There was no recurrence of HAE and hepatic echinococcosis of organs.Conclusions Segment-orientated anatomical liver resection is not only a method for complete resection,but also maximizes the functional remnant of liver on the basis of intraoperative three-dimensional reconstruction system together with selective hepatic inflow occlusion and vessel reconstruction technique.The patient gets a full recovery with satisfactory outcome.

Long-term outcomes of surgical intervention in patients with end-stage hepatic alveolar echinococcosis.

Hepatectomy for Patients with Alveolar Echinococcosis: Long-term Follow-Up Observations of 144 Cases.

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Ex vivo liver resection followed by autotransplantation for end-stage hepatic alveolar echinococcosis

“Cutting hepatectomy” for treatment of advanced giant hepatic alveolar echinococcosis:a re- port of 9 cases

Single-center experience of Ex vivo liver resection and autotransplantation for complex hepatic alveolar echinoccosis

Evaluating the Benefits and Risks of Ex Vivo Liver Resection and Autotransplantation in Treating Hepatic End-stage Alveolar Echinococcosis

In situ reconstruction of vascular inflow/outflow to left lateral liver section, ex-vivo liver resection and autologous liver transplantation of remaining liver remnant for hepatic alveolar echinococcosis

Segment-orientated anatomical liver resection for the treatment of hepatic alveolar echinococcosis in the middle lobe of the liver

Successful Treatment for End-Stage Hepatic Alveolar Echinococcosis with Ex-Vivo Liver Resection and Autologous Liver Transplantation: a Case Report

Current Status of Ex-Vivo Liver Resection and Autologous Liver Transplantation for End-Stage Hepatic Alveolar Echinococcosis.

Clinical Outcomes of Ex Vivo Liver Resection and Liver Autotransplantation for Hepatic Alveolar Echinococcosis

Initial Clinical Results of Orthotopic Liver Transplantation for Hepatic Alveolar Echinococcosis

Ex-vivo Liver Resection Combined Liver Autotransplantation for the Treatment of Hepatic Alveolar Echinococcosis

An Approach Improving Long-Term Outcome of Surgery for Hepatocellular Carcinoma: Analysis of 113 Patients Surviving More Than Five Years

Application of Associating Liver Partition and Portal Vein Ligation for Two-Stage Hepatectomy in Hepatic Alveolar Echinococcosis

Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study

Liver resection with two-step vascular exclusion, in situ hypothermic portal perfusion for the treatment of end-stage hepatic alveolar echinococcosis

Percutaneous Stenting of Left Hepatic Vein Followed by Ex Vivo Liver Resection and Autotransplantation in a Patient with Hepatic Alveolar Echinococcosis with Budd-Chiari Syndrome

Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplantation in End-Stage Hepatic Alveolar Echinococcosis with Cavernous Transformation

Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy